A detailed history of Keebeck Alpha, LP transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Keebeck Alpha, LP holds 2,690 shares of LMAT stock, worth $249,174. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,690
Previous 3,901 31.04%
Holding current value
$249,174
Previous $320,000 22.19%
% of portfolio
0.17%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$80.3 - $92.89 $97,243 - $112,489
-1,211 Reduced 31.04%
2,690 $249,000
Q2 2024

Aug 12, 2024

SELL
$62.62 - $83.59 $84,161 - $112,344
-1,344 Reduced 25.62%
3,901 $320,000
Q1 2024

May 13, 2024

BUY
$54.0 - $71.06 $283,230 - $372,709
5,245 New
5,245 $348,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.03B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.